SCHEMBL26075162

SCHEMBL26075162

CCOc1ccc(-c2cc(F)c(-c3cc(C)c4cc(F)ccc4n3)c(P)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ DHODH Q02127 4/20 0.37
▸ SCN9A Q15858 1/20 0.37
▸ CHRNA7 P36544 2/20 0.37
▸ GAA P10253 1/20 0.36
▸ PLA2G2A P14555 1/20 0.36
▸ PDE10A Q9Y233 2/20 0.36
▸ MAPT P10636 3/20 0.36
▸ TP53 P04637 3/20 0.35
▸ THRB P10828 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075167 0.89 DHODH (0.43) KDM4EALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL26075142 0.85 PDE10A (0.39) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075139 0.82 PDE10A (0.42) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075845 0.82 PDE10A (0.42) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075130 0.81 HMOX1 (0.43) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075173 0.80 SCN9A (0.42) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075298 0.79 HMOX1 (0.45) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL23590319 0.78 DHODH (0.58) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075148 0.78 PDE10A (0.43) KDM4EALDH1A1RAB9ANPC1LMNA
SCHEMBL26075184 0.77 LMNA (0.39) KDM4EALDH1A1RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD KDM4E 1396/4885ALDH1A1 88/4885RAB9A 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback